SCHEMBL10183319

SCHEMBL10183319

O=C1C(N(C(=O)CCl)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ MITF O75030 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ PAX8 Q06710 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ OPRM1 P35372 4/20 0.39
▸ OPRK1 P41145 3/20 0.39
▸ OPRL1 P41146 3/20 0.39
▸ CCKBR P32239 6/20 0.37
▸ CCKAR P32238 2/20 0.37
▸ AGTR2 P50052 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ IDH1 O75874 2/20 0.34
▸ ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183299 0.91 OPRM1 (0.40) OPRM1OPRK1OPRL1CCKBRCCKAR
SCHEMBL10183337 0.90 OPRM1 (0.39) MEN1KMT2ANPC1RAB9AOPRM1
SCHEMBL10183312 0.90 AGTR2 (0.37) MEN1KMT2AKDM4ENPC1MITF
SCHEMBL10183782 0.88 OPRM1 (0.40) OPRM1OPRK1OPRL1CCKBRCCKAR
SCHEMBL10183320 0.87 AGTR2 (0.40) OPRM1OPRK1OPRL1CCKBRAGTR2
SCHEMBL10183654 0.87 IDH1 (0.38) NPC1OPRM1OPRK1OPRL1CCKBR
SCHEMBL10184119 0.87 OPRM1 (0.37) OPRM1OPRK1OPRL1CCKBRCCKAR
SCHEMBL10184102 0.86 IDH1 (0.37) MEN1KMT2AOPRM1OPRK1OPRL1
SCHEMBL10183761 0.86 TRPM8 (0.42) MEN1KMT2AALDH1A1SMN1; SMN2OPRM1
SCHEMBL10184071 0.86 OPRM1 (0.37) NPC1OPRM1OPRK1OPRL1CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback